The New Age of Regenerative Medicine

Why Stem Cell Therapy?

USD 1,500.00

* Required Fields

USD 1,500.00


Be the first to review this product

Cell therapy is the fastest growing segment of the Regenerative Medicine (RM) industry. It comprises both immune cell therapy and stem cell therapy; however, stem cell therapy makes up the largest part of this segment. The global cell therapy market is driven by the success of stem cell treatments in treating or curing life-threatening diseases such as cancer, heart disease, and neuro-muscular ailments among the ageing population. This research study provides an overview of the regenerative medicine industry and an insight on successful stem cell therapy treatments. It also analyses marketed products, stem cell manufacturing and funding, and the collaborative partnerships in the regenerative medicine industry.

Table of Contents

The New Age of Regenerative MedicineExecutive SummaryKey FindingsKey Questions This Study Will AnswerRegenerative Medicine Industry—Where We Stand TodayRegenerative Medicine Industry—Where We Stand Today (continued)Regenerative Medicine Industry—Key StakeholdersThe New Age of Regenerative Medicine—An OverviewDefinition—Regenerative MedicineRegenerative Medicine—Market Segmentation Why is Regenerative Medicine Important to the Future of Healthcare?Market Size and Growth—Regenerative Medicine Geographical Overview for Regenerative Medicine CompaniesTotal Regenerative Medicine IndustryDefinitions—Cell Therapy and Stem Cell Therapy Cell Therapy—Commercially Available Products by TherapyOverview of Competing Products—By Development and Key ParticipantsCommercially Available Primary Cell Therapy and Allograft ProductsCommercially Available Primary Cell Therapy and Allograft Products (continued)Cellular Dynamics International (CDI), Madison, WisconsinOrthofix International, Lewisville, TexasCapricor Therapeutics, Beverly Hills, CaliforniaBig Pharmaceuticals and Regenerative MedicineStem Cell Manufacturing Facilities—Market Dynamics Market Drivers and Restraints for Stem Cell ManufacturingStem Cell Consumers Stem Cell Consumer Information—The United States Stem Cell Consumer Information—GlobalFuture TrendsFuture TrendsMarket OpportunitiesRegenerative Medicine Industry—Mergers, Acquisitions, and Partnership AssessmentGlobal Partnerships and Deals for Regenerative MedicineKey Global Partnerships and Deals for Regenerative MedicineRegenerative Medicine Industry—Funding Scenario Regenerative Medicine Market—Funding ScenarioOverview of Regenerative Medicine in Asia-PacificRegenerative Medicine—Asia-Pacific Market OverviewRegenerative Medicine—Leading APAC CountriesRegenerative Medicine—Leading APAC Countries(continued)Regenerative Medicine—Lifecycle for Leading APAC Countries Regenerative Medicine—South KoreaRegenerative Medicine—ChinaRegenerative Medicine—JapanRegenerative Medicine—SingaporeRegenerative Medicine—Key Market Access BarriersSuccessful Stem Cell Therapy Company—MEDIPOST Co., Ltd. Successful Stem Cell Therapy Company—Mesoblast Ltd.ConclusionThe Last WordLegal DisclaimerThe Frost & Sullivan StoryThe Frost & Sullivan StoryValue Proposition: Future of Your Company & CareerGlobal PerspectiveIndustry Convergence360º Research PerspectiveImplementation ExcellenceOur Blue Ocean Strategy


Related Research

Release Date : 10-Jan-18

Region : Asia Pacific

Release Date : 07-Oct-2014

Region : Global

Release Date : 05-May-2014

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.